Abstract
Currently, only a limited number of tumor markers for non-small cell lung cancer (NSCLC) are available, and NSCLC heterogeneity makes the identification of a single sensitive and specific marker unlikely. Antibodies to tumor-associated proteins may expand the number of available tumor markers for lung cancer, and may be used together in a serum profile to enhance sensitivity and specificity. Using biopan enrichment techniques with serum from NSCLC patients and healthy individuals, we isolated 57 phage-expressed proteins from two NSCLC complementary DNA T-7 phage libraries, with 45 of these having a sequence identity with known or putative tumor-associated proteins.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
